Journal article · 2021 · Open access

Primary Negative Symptoms: Refining the Research Target

Brian W Kirkpatrick, Alex S. Cohen, István Bitter, Gregory P. Strauss

Schizophrenia Bulletin, 47(5), 1207–1210 · Published 1 June 2021 · DOI 10.1093/schbul/sbab069

Open PDFView at the publisherCite this paper

In brief

“Primary Negative Symptoms: Refining the Research Target” is a 2021 journal article by Brian W Kirkpatrick and 3 co-authors, published in Schizophrenia Bulletin. OpenAlex counts 11 citations as of 20 November 2026. It is open access: the full text is free to read at Schizophrenia Bulletin.

Citations
11
Most cited in
2022 (5)
Field-weighted impact
0.83
References
20
Authors
4

Abstract

Negative symptoms contribute to poor function and quality of life in many people with schizophrenia. These symptoms often improve when there is improvement in positive psychotic symptoms—hallucinations, delusions, and disorganized thought and behavior—demonstrating that negative symptoms can be secondary to other clinical problems. To give an example, a person with schizophrenia might have the negative symptom of asocial behavior because of depression, anxiety, or overwhelming suspiciousness. However, a lack of interest in relationships is also found in people with schizophrenia who do not have these other symptoms, suggesting some negative symptoms are idiopathic or primary. People with primary negative symptoms (PNS) have poorer function than do others with schizophrenia, and this difference cannot be accounted for by differences in demographics, treatment, drug abuse, depression, or a greater severity of positive psychotic symptoms.1–3 Psychosocial treatments as well as antipsychotic, antidepressant, and anti-anxiety medications all may treat secondary negative symptoms. However, there are no established treatments for PNS. Redefining the target of research may help advance the study of this aspect of schizophrenia, as there are problems in the assessment of clinical features. First, research on PNS depends on rating scales. Rating scales are vulnerable to imprecise and invalid ratings because they rely on accurate memory of symptoms and activities over the previous week or month, an ability to self-observe accurately, and imperfect human raters. Some of these drawbacks may be particularly problematic in assessing people with PNS, since as a group they have greater cognitive impairment and less awareness of their impairment than do other people with schizophrenia.4,5 Rating scales also do not distinguish primary vs secondary negative symptoms. Digital phenotyping may offer a method of assessment that is more precise and accurate than the use of rating scales. This method for “moment-by-moment quantification of the individual-level human phenotype in situ using data from personal digital devices” 6 is well accepted by research participants with schizophrenia.7 In this approach, smart phones and wearable devices generate questions about patients’ symptoms and activities at the time, and gather objective measures such as accelerometry, physiological variables, detection of ambient speech, and automated ratings of blunted affect, many of these without the research subject having to respond. This method has been used extensively in schizophrenia, with good validity not only for positive symptoms but also for negative symptoms.8–11 There have been 2 approaches to distinguishing people with schizophrenia who have PNS from those who do not. The first is use of the Schedule for the Deficit Syndrome (SDS),12 a semistructured clinical interview tool that categorizes…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kirkpatrick, B. W., Cohen, A. S., Bitter, I., & Strauss, G. P. (2021). Primary Negative Symptoms: Refining the Research Target. Schizophrenia Bulletin, 47(5), 1207–1210. https://doi.org/10.1093/schbul/sbab069

MLA 9

Kirkpatrick, Brian W, et al. “Primary Negative Symptoms: Refining the Research Target.” Schizophrenia Bulletin, vol. 47, no. 5, 2021, pp. 1207–1210. https://doi.org/10.1093/schbul/sbab069.

Chicago

Kirkpatrick, Brian W, Alex S. Cohen, István Bitter, and Gregory P. Strauss. 2021. “Primary Negative Symptoms: Refining the Research Target.” Schizophrenia Bulletin 47 (5): 1207–1210. https://doi.org/10.1093/schbul/sbab069.

Harvard

Kirkpatrick, B. W. et al. (2021) ‘Primary Negative Symptoms: Refining the Research Target’, Schizophrenia Bulletin, 47(5), pp. 1207–1210. doi:10.1093/schbul/sbab069.

IEEE

B. W. Kirkpatrick, A. S. Cohen, I. Bitter, and G. P. Strauss, “Primary Negative Symptoms: Refining the Research Target,” Schizophrenia Bulletin, vol. 47, no. 5, pp. 1207–1210, 2021, doi: 10.1093/schbul/sbab069.

BibTeX

@article{kirkpatrick2021primary,
  title     = {{Primary Negative Symptoms: Refining the Research Target}},
  author    = {Kirkpatrick, Brian W and Cohen, Alex S. and Bitter, István and Strauss, Gregory P.},
  journal   = {Schizophrenia Bulletin},
  year      = {2021},
  volume    = {47},
  number    = {5},
  pages     = {1207--1210},
  doi       = {10.1093/schbul/sbab069},
  url       = {https://doi.org/10.1093/schbul/sbab069}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202255
202311
202533
202622

Its field-weighted citation impact is 0.83: it has been cited 0.83 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • primary negative symptoms
  • schizophrenia

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Kirkpatrick, B. W., Cohen, A. S., Bitter, I., & Strauss, G. P. (2021). Primary Negative Symptoms: Refining the Research Target. Schizophrenia Bulletin, 47(5), 1207–1210. https://doi.org/10.1093/schbul/sbab069

How many times has this paper been cited?

11 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Schizophrenia Bulletin: sign in and open the PDF from this page.

Who wrote this paper?

Brian W Kirkpatrick, Alex S. Cohen, István Bitter, Gregory P. Strauss.

What is the DOI of this paper?

10.1093/schbul/sbab069, permanently at https://doi.org/10.1093/schbul/sbab069. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.